Nurix Therapeutics Stock Price on December 19, 2024
| NRIX Stock | USD 20.02 0.19 0.96% |
Below is the normalized historical share price chart for Nurix Therapeutics extending back to July 24, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Nurix Therapeutics stands at 20.02, as last reported on the 23rd of December, with the highest price reaching 20.61 and the lowest price hitting 19.66 during the day.
If you're considering investing in Nurix Stock, it is important to understand the factors that can impact its price. Nurix Therapeutics has Sharpe Ratio of -0.0696, which conveys that the firm had a -0.0696% return per unit of risk over the last 3 months. Nurix Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nurix Therapeutics' Mean Deviation of 2.65, standard deviation of 3.61, and Risk Adjusted Performance of (0.06) to check out the risk estimate we provide.
At this time, Nurix Therapeutics' Sale Purchase Of Stock is fairly stable compared to the past year. Stock Based Compensation is likely to rise to about 40.7 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 191.1 M in 2024. . At this time, Nurix Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.59 in 2024, whereas Price To Sales Ratio is likely to drop 4.80 in 2024. Nurix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of July 2020 | 200 Day MA 19.9393 | 50 Day MA 23.5122 | Beta 2.2 |
Nurix |
Sharpe Ratio = -0.0696
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NRIX |
Estimated Market Risk
| 3.56 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nurix Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nurix Therapeutics by adding Nurix Therapeutics to a well-diversified portfolio.
Price Book 3.7255 | Enterprise Value Ebitda (3.35) | Price Sales 24.8952 | Shares Float 57.5 M | Wall Street Target Price 31.9412 |
Nurix Therapeutics Main Headline on 19th of December 2024
Nurix Therapeutics Receives U.S. FDA Fast Track Designation ... by finance.yahoo.com
Fast track designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenstroms MacroglobulinemiaSAN FRANCISCO, Dec. 19, 2024 -- Nurix Therapeutics, Inc. , a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today announced that the U.S. Food and Drug Administration has granted Fast Track designation for NX-5948, a highly se
Nurix Therapeutics Valuation on December 19, 2024
It is possible to determine the worth of Nurix Therapeutics on a given historical date. On December 19, 2024 Nurix was worth 20.19 at the beginning of the trading date compared to the closed value of 20.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nurix Therapeutics stock. Still, in general, we apply an absolute valuation method to find Nurix Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nurix Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nurix Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 21.18 | 21.67 | 19.60 | 20.24 | 1,351,014 | |
12/19/2024 | 20.19 | 20.43 | 19.38 | 20.04 | 977,868 |
| 19.90 | 20.61 | 19.66 | 19.83 | 2,913,842 |
| Backtest Nurix Therapeutics | | | Nurix Therapeutics History | | | Nurix Therapeutics Valuation | Previous | Next |
Nurix Therapeutics Trading Date Momentum on December 19, 2024
| On December 20 2024 Nurix Therapeutics was traded for 19.83 at the closing time. The top price for the day was 20.61 and the lowest listed price was 19.66 . The trading volume for the day was 2.9 M. The trading history from December 20, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.05% . The trading delta at closing time against the current closing price is 1.05% . |
Nurix Therapeutics Fundamentals Correlations and Trends
By evaluating Nurix Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nurix Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nurix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nurix Therapeutics Stock history
Nurix Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nurix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nurix Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nurix Therapeutics stock prices may prove useful in developing a viable investing in Nurix Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 62.5 M | 39.7 M | |
| Net Loss | -162.3 M | -154.2 M |
Nurix Therapeutics Quarterly Net Working Capital |
|
Nurix Therapeutics Stock Technical Analysis
Nurix Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Nurix Therapeutics Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Nurix Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nurix Therapeutics December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Nurix Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nurix Therapeutics shares will generate the highest return on investment. By undertsting and applying Nurix Therapeutics stock market strength indicators, traders can identify Nurix Therapeutics entry and exit signals to maximize returns
Nurix Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nurix Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Nurix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nurix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.18) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Nurix Stock Analysis
When running Nurix Therapeutics' price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.